申请人:——
公开号:US20040014816A1
公开(公告)日:2004-01-22
The present invention provides an aliphatic compound represented by the following formula (I) or pharmacologically acceptable salts thereof:
1
where n denotes an integer of 1 to 11, and 1 denotes an integer of 1 to 16,
the aliphatic compound being an optical isomer of the (2R,3S,2′S) configuration when the 8-position thereof is a double bond, or an optical isomer of the (2S,3R,2′RS) configuration when the 8-position is a single bond; methods for producing the compound or pharmacologically acceptable salts thereof; and uses of the compound in the treatment of cardiovascular diseases (e.g. arteriosclerosis, cardiac diseases), cancer, rheumatism, diabetic retinopathy, and respiratory diseases.
本发明提供了一种由以下式(I)表示的脂肪族化合物或其药理学上可接受的盐:其中n表示1到11的整数,l表示1到16的整数,当其8位点为双键时,该脂肪族化合物为(2R,3S,2′S)构型的光学异构体,或者当8位点为单键时,为(2S,3R,2′RS)构型的光学异构体;制备该化合物或其药理学上可接受的盐的方法;以及该化合物在治疗心血管疾病(如动脉硬化、心脏疾病)、癌症、风湿病、糖尿病视网膜病变和呼吸系统疾病中的用途。